ArticleJournal for immunotherapy of cancer2022
Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56
Irene Veneziani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this paperpooled ittrialcites it